[go: up one dir, main page]

GB761061A - Method for producing preparations with protracted acth-effect and such preparations - Google Patents

Method for producing preparations with protracted acth-effect and such preparations

Info

Publication number
GB761061A
GB761061A GB16730/53A GB1673053A GB761061A GB 761061 A GB761061 A GB 761061A GB 16730/53 A GB16730/53 A GB 16730/53A GB 1673053 A GB1673053 A GB 1673053A GB 761061 A GB761061 A GB 761061A
Authority
GB
United Kingdom
Prior art keywords
acid
acth
preparations
protracted
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB16730/53A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo AB
Original Assignee
Leo AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo AB filed Critical Leo AB
Publication of GB761061A publication Critical patent/GB761061A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35—Corticotropin [ACTH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Preparations with protracted ACTH effect are produced by combining ACTH or ACTH peptides in an aqueous medium with a high molecular weight organic compound containing acid groups derived from sulphuric, phosphoric or thiophosporic acid. The molecular weight should be at least 2000 but not so high that the compound is insoluble in water or weakly alkaline solutions. The acid groups may be introduced by esterification. Specified naturally occurring materials include heparin (which contains acid sulphuric acid ester groups) and compounds such as agar, carageen, alginic acid, dextran and hyaluronic acid which contain esterifiable carbohydrate or carbohydrate-like residues in the molecule. An exhaustive list of synthetic substances which may be sulphated or phosporylated is given. Specifications 700,761 [Group IV(b)], 753,319 and 757,800 [both in Group IV(a)] are referred to.
GB16730/53A 1952-06-21 1953-06-17 Method for producing preparations with protracted acth-effect and such preparations Expired GB761061A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK761061X 1952-06-21

Publications (1)

Publication Number Publication Date
GB761061A true GB761061A (en) 1956-11-07

Family

ID=8152668

Family Applications (1)

Application Number Title Priority Date Filing Date
GB16730/53A Expired GB761061A (en) 1952-06-21 1953-06-17 Method for producing preparations with protracted acth-effect and such preparations

Country Status (1)

Country Link
GB (1) GB761061A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3092428A (en) * 1960-10-31 1963-06-04 Rex R Kerschner Tool box
WO2012172433A3 (en) * 2011-06-14 2013-01-31 Ipsen Pharma S.A.S. A sustained -release composition containing a melanocortin receptor ligand as the active ingredient

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3092428A (en) * 1960-10-31 1963-06-04 Rex R Kerschner Tool box
WO2012172433A3 (en) * 2011-06-14 2013-01-31 Ipsen Pharma S.A.S. A sustained -release composition containing a melanocortin receptor ligand as the active ingredient
CN103608003A (en) * 2011-06-14 2014-02-26 益普生制药股份有限公司 A sustained-release composition containing a melanocortin receptor ligand as the active ingredient
CN103608003B (en) * 2011-06-14 2016-05-04 益普生制药股份有限公司 Contain the slow releasing composition of melanocortin receptor ligands as active component
US9415012B2 (en) 2011-06-14 2016-08-16 Ipsen Pharma S.A.S. Sustained-release composition containing peptides as active ingredient

Similar Documents

Publication Publication Date Title
CH257730A (en) Process for the preparation of a new high polymer, linear ester.
GB760490A (en) Lubricants for refrigerating systems
GB761061A (en) Method for producing preparations with protracted acth-effect and such preparations
CH309321A (en) Process for producing an electrical contact and electrical contact produced according to this process.
CH254542A (en) Process for the preparation of a high polymer, linear ester.
Curvall et al. Modification of polysaccharides containing uronic acid residues
Patrick Inhibition of strontium and calcium uptake by rat duodenal slices: Comparison of polyuronides and related substances
CH485724A (en) Process for the preparation of low molecular weight alkyl esters of 1,4-dihydroquinoline-N-carbonic and -thionic acid
CH432004A (en) Process for the production of high molecular weight acetone-soluble polyethers
Arene et al. The inter-relation of utilin and entandrophragmin
Shilo et al. Promotion of infection by intravenously administered polysaccharides
AT270227B (en) Process for the production of high molecular weight mixed polyether esters
GB1000684A (en) Diol derivative of 9-oxabicyclo(3,3,1)nonane
GB1232885A (en)
GB1473056A (en) Production of acid cleaning compositions
CA609715A (en) Process for preparing high molecular weight linear polyesters from monoepoxides
GB667039A (en) Improvements in and relating to the manufacture of preparations containing the anti-pernicious anaemia factor
GB676232A (en) Improvements in and relating to the production of cellulose esters
GB364807A (en) Improvements in or relating to the production of plastic masses from cellulose esters and ethers
GB706410A (en) Method of producing poly-condensed phosphoric acid esters
AT182713B (en) Process for the production of conversion products of high molecular weight carbohydrates or their derivatives
GB819679A (en) Improvements in or relating to high polymers
GB290464A (en) Improvements in the manufacture and production of lactic acid and its derivatives
GB226142A (en) Process for the purification or dehydration of cellullose esters and ethers used alone or in admixture with organic or inorganic substances
Zhou THE MORPHOLOGY OF CARPAL GLANDS AND THEIR DIFFERENCES BETWEEN NORTHEASTERN NATIVE AND HARBIN WHITE PIGS